Inactive Instrument

Company Neuralstem, Inc. Nyse

Equities

US64127R3021

End-of-day quote Nyse Other stock markets
- ^USD	-

Apr. 16	Sector Update: Health Care Stocks Edge Up Tuesday Afternoon	MT
Apr. 16	Palisade Bio Shows Bioactivation of PALI-2108 in Study; Shares Rise	MT

Business Summary

Seneca Biopharma, Inc., formerly Neuralstem, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for diseases of unmet medical need. It is focused on finding and acquiring new assets, sciences and technologies that provide therapies for patients. It intends to focus on developing a pipeline of biopharmaceuticals and commercializing those products.

Managers

Managers	Age	Since
Nicholas McCoy	-	-
Ryker Willie	-	-
Charles C. Wells	73	-
J. D. Finley	66	-
Mitchell Jones	46	-

Members of the board

Members of the board	Title	Age	Since
Donald Williams		65	-
J. D. Finley		66	-
Bin Xian Wei BRD	Director/Board Member	54	19-02-04

Company contact information

Seneca Biopharma, Inc.

20271 Goldenrod Lane Suite 2024

20876, Germantown

+301 366 4841

https://www.palisadebio.com

Sector

This company's sector is not yet available